Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome

Peter Tsvetkov(Whitehead Institute for Biomedical Research), Marc L. Mendillo(Howard Hughes Medical Institute), Jinghui Zhao(Harvard University), Jan E. Carette(Stanford University), Parker Merrill(Brigham and Women's Hospital), Domagoj Cikes(Institute of Molecular Biotechnology), Malini Varadarajan(Whitehead Institute for Biomedical Research), Ferdy R. van Diemen(The Netherlands Cancer Institute), Josef Penninger(Institute of Molecular Biotechnology), Alfred L. Goldberg(Harvard University), Thijn R. Brummelkamp(The Netherlands Cancer Institute), Sandro Santagata(Brigham and Women's Hospital), Susan Lindquist(Howard Hughes Medical Institute)
eLife
August 28, 2015
Cited by 86Open Access
Full Text

Abstract

Proteasomes are central regulators of protein homeostasis in eukaryotes. Proteasome function is vulnerable to environmental insults, cellular protein imbalance and targeted pharmaceuticals. Yet, mechanisms that cells deploy to counteract inhibition of this central regulator are little understood. To find such mechanisms, we reduced flux through the proteasome to the point of toxicity with specific inhibitors and performed genome-wide screens for mutations that allowed cells to survive. Counter to expectation, reducing expression of individual subunits of the proteasome's 19S regulatory complex increased survival. Strong 19S reduction was cytotoxic but modest reduction protected cells from inhibitors. Protection was accompanied by an increased ratio of 20S to 26S proteasomes, preservation of protein degradation capacity and reduced proteotoxic stress. While compromise of 19S function can have a fitness cost under basal conditions, it provided a powerful survival advantage when proteasome function was impaired. This means of rebalancing proteostasis is conserved from yeast to humans.


Related Papers

No related papers found

Powered by citation graph analysis